Articles From: AstraZeneca Approved For Diabetes Treatment to Bank of Communications: Time for a Withdrawal? -- Barron's Asia


2014/10/30
LONDON--British-Swedish drugmaker AstraZeneca PLC (AZN.LN) said Thursday it received approval from the U.S. Food and Drug Administration for Xigduo XR as a daily treatment for type 2 diabetes.
Sign-up for AstraZeneca Approved For Diabetes Treatment investment picks
2014/10/30
By Ed Ballard LONDON--British-Swedish drugmaker AstraZeneca PLC (AZN.LN) said Thursday it received approval from the U.S. Food and Drug Administration for Xigduo XR as a daily treatment for type 2 diabetes.
Sign-up for AstraZeneca Gets U.S. Approval For Xigduo XR Diabetes Treatment investment picks
2014/10/30
By Jack Nicas A small plane crashed into a building at Wichita Mid-Continent Airport in Kansas, shortly after takeoff on Thursday morning, killing at least four people, authorities said.
Sign-up for At Least 4 Dead After Small Plane Crash at Kansas Airport -- 2nd Update investment picks
2014/10/30
By Jack Nicas A small plane crashed into a building at a Wichita, Kan., airport shortly after takeoff on Thursday, killing four people.
Sign-up for At Least 4 Dead After Small Plane Crash at Kansas Airport -- 3rd Update investment picks
http://media.marketwire.com/attachments/201410/81039_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155435&ProfileId=051205&sourceType=1 BEIJING, CHINA --
Sign-up for ATA Announces Strategic Investment in China Tutorial Services Company Master Mind Education investment picks
ATK Second Quarter Year-Over-Year Sales Increased 11 percent ATK Second Quarter Year-Over-Year Operating Profit Increased 8 percent ATK Second Quarter Year-Over-Year EPS Increased 4 percent ATK Updates its FY15 Sales Guidance and Reaffirms its FY15 EPS and Free Cash Flow Guidance ARLINGTON, Va.
Sign-up for ATK Reports FY15 Second Quarter Operating Results investment picks
http://media.marketwire.com/attachments/201303/58144_ATOSSALOGO.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155430&ProfileId=051205&sourceType=1 SEATTLE, WA --
Sign-up for Atossa Genetics Inc. Wins Dismissal of Securities Class Action Litigation investment picks
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (“Afib”) and Left Atrial Appendage Management (“LAAM”), today announced financial results for the third quarter of 2014.
Sign-up for AtriCure Reports Third Quarter 2014 Financial Results and Updates 2014 Outlook investment picks
2014/10/30
Total non-GAAP revenue grew 45% to a new record of $9.5 million Non-GAAP operating income of $1.2 million BURLINGTON, Mass.
Sign-up for Attunity Reports Third Quarter 2014 Financial Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155236&ProfileId=051205&sourceType=1 MOUNTAIN VIEW, CA --
Sign-up for Audience Announces Third Quarter 2014 Financial Results investment picks
Third quarter revenues increase 11.2% year-over-year to $38.9 million LOD, Israel, Oct.
Sign-up for AudioCodes Reports Third Quarter 2014 Results investment picks
LA JOLLA, Calif., Oct.
Sign-up for Auspex Pharmaceuticals Initiates Second Pivotal Clinical Trial for SD-809 in Tardive Dyskinesia investment picks
2014/10/30
By Robb M.
Sign-up for Australia & New Zealand Banking Group Fiscal Year Profit Rises 15% investment picks
Autodesk, Inc. (NASDAQ: ADSK) has announced that it intends to invest up to $100 million in 3D printing companies over the next several years.
Sign-up for Autodesk Announces $100 Million Spark Investment Fund, the World’s First 3D Printing Investment Program investment picks
$109.6 Million in 3Q 2014 Net Revenues Driven by Strong XIAFLEX Growth; Company Returns to Profitability with 3Q Non-GAAP EPS of $0.27 per Share CHESTERBROOK, Pa.
Sign-up for Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results investment picks
Third Quarter 2014 Highlights - as compared to the prior year quarter (unless otherwise noted) SCOTTSDALE, Ariz., Oct.
Sign-up for AV Homes Reports Results for Third Quarter 2014 investment picks
MENLO PARK, Calif., Oct.
Sign-up for Avalanche Biotechnologies to Participate in Nomura's Biotechnology Conference investment picks
2014/10/30
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155145&ProfileId=051205&sourceType=1 LONDON, UNITED KINGDOM --
Sign-up for Aviva PLC Announces 3Q 2014 IMS investment picks
Avon Products Inc. (AVP) said Thursday it had net income of $91.4 million, or 21 cents a share, in the third quarter, after a loss of $5.5 million, or 1 cent a share, in the same period a year ago.
Sign-up for Avon Products beats profit estimates, buoyed by strength in Europe investment picks
Third-Quarter Revenue Down 8%; Up 1% in Constant Dollars(1) Operating Profit $188 Million; Adjusted(1) Operating Profit $198 Million Operating Margin 8.8%, up from 2.9% in the Third-Quarter 2013 Adjusted(1) Operating Margin 9.3%, up from 5.4% in the Third-Quarter 2013 NEW YORK , Oct.
Sign-up for Avon Reports Third-Quarter 2014 Results investment picks
http://media.marketwire.com/attachments/201401/70455_axt.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155297&ProfileId=051205&sourceType=1 FREMONT, CA --
Sign-up for AXT, Inc. Announces $5 Million Stock Repurchase Program investment picks
Highlights --
Sign-up for Ball Reports Third Quarter Results investment picks
Banc of California, Inc. (NYSE: BANC) today reported net income of $11.2 million and net income available to common shareholders of $10.3 million, or $0.31 per diluted common share for the quarter ended September 30, 2014.
Sign-up for Banc of California Reports Third Quarter Results investment picks
SAO PAULO , Oct.
Sign-up for Banco Bradesco 3Q14 Results investment picks
2014/10/30
BEIJING--Bank of China Ltd.(3988.HK) said Thursday its third-quarter net profit rose 5% from a year earlier, boosted by higher interest income.
Sign-up for Bank of China 3Q Net Profit up 5% at CNY41.41 Billion investment picks
2014/10/30
By Isabella Zhong It's said that size matters.
Sign-up for Bank of Communications: Time for a Withdrawal? -- Barron's Asia investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: AstraZeneca Approved For Diabetes Treatment to Bank of Communications: Time for a Withdrawal? -- Barron's Asia
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent